- India
- /
- Healthcare Services
- /
- NSEI:NH
Shareholders May Be More Conservative With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation For Now
Key Insights
- Narayana Hrudayalaya's Annual General Meeting to take place on 29th of August
- Total pay for CEO Emmanuel Rupert includes ₹67.6m salary
- The total compensation is 279% higher than the average for the industry
- Over the past three years, Narayana Hrudayalaya's EPS grew by 28% and over the past three years, the total shareholder return was 166%
Under the guidance of CEO Emmanuel Rupert, Narayana Hrudayalaya Limited (NSE:NH) has performed reasonably well recently. In light of this performance, CEO compensation will probably not be the main focus for shareholders as they go into the AGM on 29th of August. However, some shareholders may still want to keep CEO compensation within reason.
See our latest analysis for Narayana Hrudayalaya
How Does Total Compensation For Emmanuel Rupert Compare With Other Companies In The Industry?
According to our data, Narayana Hrudayalaya Limited has a market capitalization of ₹368b, and paid its CEO total annual compensation worth ₹92m over the year to March 2025. We note that's an increase of 23% above last year. Notably, the salary which is ₹67.6m, represents most of the total compensation being paid.
In comparison with other companies in the Indian Healthcare industry with market capitalizations ranging from ₹175b to ₹560b, the reported median CEO total compensation was ₹24m. Hence, we can conclude that Emmanuel Rupert is remunerated higher than the industry median.
| Component | 2025 | 2024 | Proportion (2025) | 
| Salary | ₹68m | ₹54m | 73% | 
| Other | ₹25m | ₹21m | 27% | 
| Total Compensation | ₹92m | ₹75m | 100% | 
On an industry level, roughly 97% of total compensation represents salary and 3% is other remuneration. In Narayana Hrudayalaya's case, non-salary compensation represents a greater slice of total remuneration, in comparison to the broader industry. If salary dominates total compensation, it suggests that CEO compensation is leaning less towards the variable component, which is usually linked with performance.
A Look at Narayana Hrudayalaya Limited's Growth Numbers
Narayana Hrudayalaya Limited's earnings per share (EPS) grew 28% per year over the last three years. It achieved revenue growth of 11% over the last year.
Shareholders would be glad to know that the company has improved itself over the last few years. This sort of respectable year-on-year revenue growth is often seen at a healthy, growing business. Moving away from current form for a second, it could be important to check this free visual depiction of what analysts expect for the future.
Has Narayana Hrudayalaya Limited Been A Good Investment?
We think that the total shareholder return of 166%, over three years, would leave most Narayana Hrudayalaya Limited shareholders smiling. So they may not be at all concerned if the CEO were to be paid more than is normal for companies around the same size.
To Conclude...
The company's decent performance might have made most shareholders happy, possibly making CEO remuneration the least of the concerns to be discussed in the upcoming AGM. However, if the board proposes to increase the compensation, some shareholders might have questions given that the CEO is already being paid higher than the industry.
If you think CEO compensation levels are interesting you will probably really like this free visualization of insider trading at Narayana Hrudayalaya.
Arguably, business quality is much more important than CEO compensation levels. So check out this free list of interesting companies that have HIGH return on equity and low debt.
Valuation is complex, but we're here to simplify it.
Discover if Narayana Hrudayalaya might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:NH
Narayana Hrudayalaya
Provides medical and healthcare services in India and the Cayman Islands.
Flawless balance sheet with reasonable growth potential.
Market Insights
Community Narratives


